• Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 42 Tests Non-CLIA Waived - KT/1 - 430000-KT
1 1

Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 42 Tests Non-CLIA Waived - Kit - 430000-KT

Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 42 Tests Non-CLIA Waived - Kit - 430000-KT

SKU

430000-KT
$953.99
$953.99
OFF Sold out
Shipping calculated at checkout.

In stock

  • American Express
  • Diners Club
  • Discover
  • Mastercard
  • Shop Pay
  • Visa
View full details
Description

Abbott Rapid Dx North America LLC Respiratory Test Kit BinaxNOW® Infectious Disease Immunoassay Respiratory Syncytial Virus Test (RSV) Nasopharyngeal Swab / Nasal Wash Sample 42 Tests Non-CLIA Waived

This Respiratory Test Kit from BinaxNOW® is ideal for clinics, laboratories and point-of-care testing. Sold as a kit.

MF Id# 430000
Brand BinaxNOW®
Manufacturer Abbott Rapid Dx North America LLC
Country of Origin United States
Application Respiratory Test Kit
CLIA Classification Non-CLIA Waived
CLIA Classified CLIA Non-Waived
Contents 1 (42) Test Cards, Transfer Pipettes, Positive Control Swab, Negative Control Swab, Product Insert, Procedure Card
Number of Tests 42 Tests
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Purchase Program Type Standard Purchase
Reading Type Visual Read
Sample Type Nasopharyngeal Swab / Nasal Wash Sample
Specialty Immunoassay
Test Format Test Card Format
Test Method Lateral Flow Method
Test Name Respiratory Syncytial Virus Test (RSV)
Test Type Infectious Disease Immunoassay
Time to Results 15 Minute Results
UNSPSC Code 41116144

Features

  • Alere BinaxNOW® RSV Card is an in vitro rapid immunochromatographic assay used to detect respiratory syncytial virus (RSV) fusion protein antigen in nasal wash and nasopharyngeal (NP) swab specimens from symptomatic patients
  • It is intended to aid in the diagnosis of RSV infections in patients under the age of 5
  • Retrospective nasal wash Sensitivity: 89% Specificity: 100%
  • Prospective NP swab Sensitivity: 93% Specificity 93%